Spirohydantoin tricyclic CGRP receptor antagonists

Details for Australian Patent Application No. 2006316644 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Theberge, Cory R.; Bell, Ian M.; Gallicchio, Steven N.; Zartman, C. Blair; Stump, Craig A.

Agent Spruson & Ferguson

Pub. Number AU-B-2006316644

PCT Pub. Number WO2007/061694

Priority 60/738,332 18.11.05 US

Filing date 14 November 2006

Wipo publication date 31 May 2007

Acceptance publication date 10 November 2011

International Classifications

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

A01N 43/62 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/061694 Priority application(s): WO2007/061694

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

10 November 2011 Application Accepted

  Published as AU-B-2006316644

8 March 2012 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006316645-Bicyclic spirohydantoin CGRP receptor antagonists

2006316642-Spirolactam tricyclic CGRP receptor antagonists